CN112048477A - Ebv病毒感染人工呼吸道上皮模型的建立方法 - Google Patents
Ebv病毒感染人工呼吸道上皮模型的建立方法 Download PDFInfo
- Publication number
- CN112048477A CN112048477A CN202010842946.8A CN202010842946A CN112048477A CN 112048477 A CN112048477 A CN 112048477A CN 202010842946 A CN202010842946 A CN 202010842946A CN 112048477 A CN112048477 A CN 112048477A
- Authority
- CN
- China
- Prior art keywords
- ebv
- cells
- cell
- ebv virus
- epithelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 210000001533 respiratory mucosa Anatomy 0.000 title claims abstract description 13
- 230000009385 viral infection Effects 0.000 title claims description 12
- 210000004027 cell Anatomy 0.000 claims abstract description 54
- 241000700605 Viruses Species 0.000 claims abstract description 21
- 210000002919 epithelial cell Anatomy 0.000 claims abstract description 20
- 239000012528 membrane Substances 0.000 claims abstract description 17
- 210000004379 membrane Anatomy 0.000 claims abstract description 15
- 206010015108 Epstein-Barr virus infection Diseases 0.000 claims abstract description 13
- 238000012258 culturing Methods 0.000 claims abstract description 13
- 210000002345 respiratory system Anatomy 0.000 claims abstract description 8
- 108010007093 dispase Proteins 0.000 claims abstract description 7
- 210000004877 mucosa Anatomy 0.000 claims abstract description 6
- 210000001519 tissue Anatomy 0.000 claims abstract description 6
- 238000010009 beating Methods 0.000 claims abstract description 5
- 230000001404 mediated effect Effects 0.000 claims abstract description 5
- 239000013049 sediment Substances 0.000 claims abstract description 5
- 239000006143 cell culture medium Substances 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims abstract description 4
- 208000015181 infectious disease Diseases 0.000 claims description 19
- 239000001963 growth medium Substances 0.000 claims description 13
- 230000029087 digestion Effects 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
- 108020004518 RNA Probes Proteins 0.000 claims description 4
- 239000003391 RNA probe Substances 0.000 claims description 4
- 210000004081 cilia Anatomy 0.000 claims description 4
- 108091034120 Epstein–Barr virus-encoded small RNA Proteins 0.000 claims description 3
- 108010019160 Pancreatin Proteins 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 210000003097 mucus Anatomy 0.000 claims description 3
- 229940055695 pancreatin Drugs 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000003834 intracellular effect Effects 0.000 claims description 2
- 238000007899 nucleic acid hybridization Methods 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 239000012894 fetal calf serum Substances 0.000 claims 2
- 238000010899 nucleation Methods 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 abstract description 12
- 239000007788 liquid Substances 0.000 abstract description 8
- 230000000241 respiratory effect Effects 0.000 abstract description 4
- 210000000254 ciliated cell Anatomy 0.000 abstract description 3
- 239000011148 porous material Substances 0.000 abstract description 3
- 230000003248 secreting effect Effects 0.000 abstract description 3
- 210000002175 goblet cell Anatomy 0.000 abstract description 2
- 230000001886 ciliary effect Effects 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 9
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 8
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 7
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 6
- 210000003719 b-lymphocyte Anatomy 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 208000011691 Burkitt lymphomas Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002955 secretory cell Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000445924 Epiphyllum <angiosperm> Species 0.000 description 1
- 239000001922 Gum ghatti Substances 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 101000972282 Homo sapiens Mucin-5AC Proteins 0.000 description 1
- 102100022496 Mucin-5AC Human genes 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000711902 Pneumovirus Species 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 210000001552 airway epithelial cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 201000006747 infectious mononucleosis Diseases 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000010576 undifferentiated carcinoma Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000009447 viral pathogenesis Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16241—Use of virus, viral particle or viral elements as a vector
- C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010842946.8A CN112048477B (zh) | 2020-08-20 | 2020-08-20 | Ebv病毒感染人工呼吸道上皮模型的建立方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010842946.8A CN112048477B (zh) | 2020-08-20 | 2020-08-20 | Ebv病毒感染人工呼吸道上皮模型的建立方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112048477A true CN112048477A (zh) | 2020-12-08 |
CN112048477B CN112048477B (zh) | 2023-06-30 |
Family
ID=73601007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010842946.8A Active CN112048477B (zh) | 2020-08-20 | 2020-08-20 | Ebv病毒感染人工呼吸道上皮模型的建立方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112048477B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114908037A (zh) * | 2022-05-17 | 2022-08-16 | 郑州大学第五附属医院 | 人肠上皮化生气液界面模型的培养基、构建方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102812924A (zh) * | 2012-02-28 | 2012-12-12 | 中国医学科学院医学生物学研究所 | 一种ebv病毒豚鼠动物模型的建立方法 |
CN105255833A (zh) * | 2015-10-13 | 2016-01-20 | 陕西博溪生物科技有限公司 | 一种口腔黏膜上皮模型及其体外构建方法 |
WO2022261293A1 (en) * | 2021-06-09 | 2022-12-15 | The Regents Of The University Of California | Lung organoid model and method of use |
-
2020
- 2020-08-20 CN CN202010842946.8A patent/CN112048477B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102812924A (zh) * | 2012-02-28 | 2012-12-12 | 中国医学科学院医学生物学研究所 | 一种ebv病毒豚鼠动物模型的建立方法 |
CN105255833A (zh) * | 2015-10-13 | 2016-01-20 | 陕西博溪生物科技有限公司 | 一种口腔黏膜上皮模型及其体外构建方法 |
WO2022261293A1 (en) * | 2021-06-09 | 2022-12-15 | The Regents Of The University Of California | Lung organoid model and method of use |
Non-Patent Citations (2)
Title |
---|
PHILLIP ZIEGLER ET AL.: "A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection", 《PLOS PATHOGENS》 * |
冀晓丽 等: "气液界面培养小鼠气管上皮细胞模型构建", 《中国药理学通报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114908037A (zh) * | 2022-05-17 | 2022-08-16 | 郑州大学第五附属医院 | 人肠上皮化生气液界面模型的培养基、构建方法和应用 |
CN114908037B (zh) * | 2022-05-17 | 2024-06-25 | 郑州大学第五附属医院 | 人肠上皮化生气液界面模型的培养基、构建方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112048477B (zh) | 2023-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11696949B2 (en) | Coronavirus-targeting universal DC cell vaccine, and preparation method and use thereof | |
CN111454878B (zh) | 类器官病毒感染模型的构建方法和应用 | |
CN112410290B (zh) | 一种大口黑鲈心肌成纤维细胞系及应用 | |
CN113025574B (zh) | 一种大口黑鲈脑细胞系及其应用 | |
CN102965341B (zh) | 人脐带间充质干细胞系及其建立方法和应用 | |
CN110551689B (zh) | 一种乌斑鳢脑细胞系及其构建方法和应用 | |
CN113684190B (zh) | 一种圆圈病毒3型双拷贝全长基因感染性克隆质粒及其构建方法和应用 | |
WO2011050672A1 (zh) | 肝炎病毒体外培养模型及其构建方法与应用 | |
CN102304491A (zh) | 半滑舌鳎精巢细胞系的构建与鉴定方法 | |
CN112143702A (zh) | 一种神经纤维瘤细胞系及其构建方法 | |
CN112048477B (zh) | Ebv病毒感染人工呼吸道上皮模型的建立方法 | |
Danner et al. | In vitro studies on Borna virus: I. The use of cell cultures for the demonstration, titration and production of Borna virus | |
CN105713866B (zh) | 人巨细胞病毒感染性克隆及其构建方法和应用 | |
US5994115A (en) | Artificial system for the production of infectious human papillomavirus | |
CN108486156B (zh) | 一种永生化树鼩小肠上皮细胞系及其构建方法与应用 | |
CN104531607B (zh) | 犬原代细支气管上皮细胞及其在制备永生化细胞中的应用 | |
Beckmann et al. | Propagation and primary isolation of papovavirus JC in epithelial cells derived from human urine | |
CN112852751A (zh) | 一种新冠肺炎核酸检测质控病毒的制备及质控方法 | |
CN101445791A (zh) | 一种筛选多潜能细胞的方法及其专用培养基 | |
CN109680000B (zh) | 利用树鼩骨髓间充干细胞建立hcv细胞模型的方法 | |
CN113881692A (zh) | 宿主细胞针对新冠病毒侵入的防御分子筛选评价方法 | |
CN114107223B (zh) | 利用TPCK胰酶提高SARS-CoV-2病毒细胞培养滴度的方法 | |
Dong et al. | Primary Tree Shrew Dermis Fibroblasts Support Lytic Replication of Human Cytomegalovirus | |
CN112175995B (zh) | 一种vsx2绿色荧光报告基因载体系统及其构建方法 | |
WO2022149717A1 (ko) | 상기도 조직 유래 세포 기반 바이러스 감염위해성 생체외 분석방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231201 Address after: 250101 Export Processing Zone, Jinan High-tech Zone, Shandong Province, 1109 Gangxing Third Road Patentee after: Shandong Yinfeng Institute of Life Sciences Patentee after: YINFENG BIOLOGICAL GROUP Co.,Ltd. Patentee after: SHAANXI STEM CELL ENGINEERING Co.,Ltd. Address before: 250101 Export Processing Zone, Jinan High-tech Zone, Shandong Province, 1109 Gangxing Third Road Patentee before: Shandong Yinfeng Institute of Life Sciences Patentee before: YINFENG BIOLOGICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240222 Address after: 250101 Export Processing Zone, Jinan High-tech Zone, Shandong Province, 1109 Gangxing Third Road Patentee after: Shandong Yinfeng Institute of Life Sciences Country or region after: China Patentee after: YINFENG BIOLOGICAL GROUP Co.,Ltd. Patentee after: SHAANXI STEM CELL ENGINEERING Co.,Ltd. Patentee after: Chongqing Yinfeng Bioengineering Co.,Ltd. Address before: 250101 Export Processing Zone, Jinan High-tech Zone, Shandong Province, 1109 Gangxing Third Road Patentee before: Shandong Yinfeng Institute of Life Sciences Country or region before: China Patentee before: YINFENG BIOLOGICAL GROUP Co.,Ltd. Patentee before: SHAANXI STEM CELL ENGINEERING Co.,Ltd. |
|
TR01 | Transfer of patent right |